Nezāles neiznīkst ([info]jan09) rakstīja,
@ 2021-11-04 14:58:00

Previous Entry  Add to memories!  Tell a Friend!  Next Entry
dt
dienas tablete:

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today.

https://www.gov.uk/government/news/first-oral-antiviral-for-covid-19-lagevrio-molnupiravir-approved-by-mhra


(Lasīt komentārus)

Nopūsties:

No:
Lietotājvārds:
Parole:
Ievadi te 'qws' (liidzeklis pret spambotiem):
Temats:
Tematā HTML ir aizliegts
  
Ziņa:

Gandrīz jau aizmirsu pateikt – šis lietotājs ir ieslēdzis IP adrešu noglabāšanu. Operatore Nr. 65.
Neesi iežurnalējies. Iežurnalēties?